Grant: Fellowship: LLSC/CIHR Clinician Scientist Fellow Award
University of British Columbia
$99,165.00
Molecular Determinants of Clinical Outcomes In High-Grade B-cell Lymphoma
FY 2021-22
Summary
Aggressive B-cell lymphoma is a cancer of the immune system that affects 4000 Canadians annually. Despite available treatments, one-third of afflicted patients die of their disease. This project will use detailed genetic analysis of lymphoma samples to help better predict which patients will not respond to current treatments so that their treatment can be improved and discover new treatments that target the genetic defects in these cancers.
Department
Program
Fellowship: LLSC/CIHR Clinician Scientist Fellow Award
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
465681
Name
Alduaij Waleed
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Leukemia & Lymphoma Society of Canada (Toronto, Ontario)
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Molecular Determinants of Clinical Outcomes In High-Grade B-cell Lymphoma
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$99,165
Cihrequipment2
$0
Programname2
Fellowship: LLSC/CIHR Clinician Scientist Fellow Award
Keyworddelim
Blood Cancer; Cancer; Lymphoma
Abstract
Aggressive B-cell lymphoma is a cancer of the immune system that affects 4000 Canadians annually. Despite available treatments, one-third of afflicted patients die of their disease. This project will use detailed genetic analysis of lymphoma samples to help better predict which patients will not respond to current treatments so that their treatment can be improved and discover new treatments that target the genetic defects in these cancers.
Competitiondate
202202
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Alduaij, Waleed
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $99,165~ $0~